ArticleFrontiers in microbiology2025
Changes in the gut microbiome of older adults according to hypertension control.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Exploratory metabolomic profiling reveals metabolic alterations potentially associated with pain and blood pressure regulation in a high-sugar diet rat model.Scientific reports · 2026Article
- Article
- Taxonomic and functional remodeling of the gut microbiota during aging and implications for microbiota-derived biomarkers.World journal of microbiology & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is the leading cause of cardiovascular disease, with over 60% prevalence in older adults, and its control is complex and requires multidisciplinary approaches. The role of the gut microbiome in blood pressure control remains unclear despite reported associations of some specific bacteria involved in the development of hypertension. The aim of this study was to characterize the gut microbiome of older adults and to identify bacteria associated with hypertension control. Patients aged 60 years and older from Mexico City and the metropolitan area, all of whom were receiving antihypertensive treatment, provided a feces sample during a routine medical visit. DNA was extracted from 240 samples using a commercial kit, the V3/V4 region of the 16S gene was sequenced, and metataxonomic analyses were performed using QIIME and R. Bacterial abundance analysis identified a core microbiome in the hypertensive older adults, with an increased abundance of
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.